{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:20Z","timestamp":1793275340414,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K501268\/1"],"award-info":[{"award-number":["MR\/K501268\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L02053X\/1"],"award-info":[{"award-number":["MR\/L02053X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000368","name":"Brain Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["M220-F1"],"award-info":[{"award-number":["M220-F1"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The huntingtin (HTT) protein in its mutant form is the cause of the inherited neurodegenerative disorder, Huntington\u2019s disease. Beyond its effects in the central nervous system, disease-associated mutant HTT causes aberrant phenotypes in myeloid-lineage innate immune system cells, namely monocytes and macrophages. Whether the wild-type form of the protein, however, has a role in normal human macrophage function has not been determined. Here, the effects of lowering the expression of wild-type (wt)HTT on the function of primary monocyte-derived macrophages from healthy, non-disease human subjects were examined. This demonstrated a previously undescribed role for wtHTT in maintaining normal macrophage health and function. Lowered wtHTT expression was associated, for instance, with a diminished release of induced cytokines, elevated phagocytosis and increased vulnerability to cellular stress. These may well occur by mechanisms different to that associated with the mutant form of the protein, given an absence of any effect on the intracellular signalling pathway predominantly associated with macrophage dysfunction in Huntington\u2019s disease.<\/jats:p>","DOI":"10.1038\/s41598-020-74042-8","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T10:04:52Z","timestamp":1602669892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Wild-type huntingtin regulates human macrophage function"],"prefix":"10.1038","volume":"10","author":[{"given":"Grace C.","family":"O\u2019Regan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar H.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"74042_CR1","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005. https:\/\/doi.org\/10.1038\/nrdp.2015.5 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"74042_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The biology of huntingtin. Neuron 89, 910\u2013926. https:\/\/doi.org\/10.1016\/j.neuron.2016.02.003 (2016).","journal-title":"Neuron"},{"key":"74042_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao, M. P. et al. Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269, 407\u2013410. https:\/\/doi.org\/10.1126\/science.7618107 (1995).","journal-title":"Science"},{"key":"74042_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir, J. et al. Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811\u2013823 (1995).","journal-title":"Cell"},{"key":"74042_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin, S., Liu, J. P., Chapman, D. L., Papaioannou, V. E. & Efstratiadis, A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat. Genet. 11, 155\u2013163. https:\/\/doi.org\/10.1038\/ng1095-155 (1995).","journal-title":"Nat. Genet."},{"key":"74042_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White, J. K. et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat. Genet. 17, 404\u2013410. https:\/\/doi.org\/10.1038\/ng1297-404 (1997).","journal-title":"Nat. Genet."},{"key":"74042_CR7","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","volume":"10","author":"W Auerbach","year":"2001","unstructured":"Auerbach, W. et al. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum. Mol. Genet. 10, 2515\u20132523. https:\/\/doi.org\/10.1093\/hmg\/10.22.2515 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"74042_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1385\/MN:28:3:259","volume":"28","author":"A Reiner","year":"2003","unstructured":"Reiner, A., Dragatsis, I., Zeitlin, S. & Goldowitz, D. Wild-type huntingtin plays a role in brain development and neuronal survival. Mol. Neurobiol. 28, 259\u2013276. https:\/\/doi.org\/10.1385\/MN:28:3:259 (2003).","journal-title":"Mol. Neurobiol."},{"key":"74042_CR9","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1523\/JNEUROSCI.21-19-07608.2001","volume":"21","author":"A Reiner","year":"2001","unstructured":"Reiner, A. et al. Neurons lacking huntingtin differentially colonize brain and survive in chimeric mice. J. Neurosci. 21, 7608\u20137619 (2001).","journal-title":"J. Neurosci."},{"key":"74042_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","volume":"67","author":"JD Godin","year":"2010","unstructured":"Godin, J. D. et al. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67, 392\u2013406. https:\/\/doi.org\/10.1016\/j.neuron.2010.06.027 (2010).","journal-title":"Neuron"},{"key":"74042_CR11","doi-asserted-by":"publisher","first-page":"14794","DOI":"10.1523\/JNEUROSCI.2774-11.2011","volume":"31","author":"Y Tong","year":"2011","unstructured":"Tong, Y. et al. Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. J. Neurosci. 31, 14794\u201314799. https:\/\/doi.org\/10.1523\/JNEUROSCI.2774-11.2011 (2011).","journal-title":"J. Neurosci."},{"key":"74042_CR12","doi-asserted-by":"publisher","first-page":"14545","DOI":"10.1074\/jbc.C100044200","volume":"276","author":"D Rigamonti","year":"2001","unstructured":"Rigamonti, D. et al. Huntingtin\u2019s neuroprotective activity occurs via inhibition of procaspase-9 processing. J. Biol. Chem. 276, 14545\u201314548. https:\/\/doi.org\/10.1074\/jbc.C100044200 (2001).","journal-title":"J. Biol. Chem."},{"key":"74042_CR13","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti, D. et al. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 3705\u20133713 (2000).","journal-title":"J. Neurosci."},{"key":"74042_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","volume":"96","author":"BR Leavitt","year":"2006","unstructured":"Leavitt, B. R. et al. Wild-type huntingtin protects neurons from excitotoxicity. J. Neurochem. 96, 1121\u20131129. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03605.x (2006).","journal-title":"J. Neurochem."},{"key":"74042_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2202-7-80","volume":"7","author":"JM Van Raamsdonk","year":"2006","unstructured":"Van Raamsdonk, J. M., Pearson, J., Murphy, Z., Hayden, M. R. & Leavitt, B. R. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. BMC Neurosci. 7, 80. https:\/\/doi.org\/10.1186\/1471-2202-7-80 (2006).","journal-title":"BMC Neurosci."},{"key":"74042_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nn.3080","volume":"15","author":"V Lo Sardo","year":"2012","unstructured":"Lo Sardo, V. et al. An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin. Nat. Neurosci. 15, 713\u2013721. https:\/\/doi.org\/10.1038\/nn.3080 (2012).","journal-title":"Nat. Neurosci."},{"key":"74042_CR17","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","volume":"25","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y. et al. Huntingtin inhibits caspase-3 activation. EMBO J. 25, 5896\u20135906. https:\/\/doi.org\/10.1038\/sj.emboj.7601445 (2006).","journal-title":"EMBO J."},{"key":"74042_CR18","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","volume":"14","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk, J. M. et al. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 14, 1379\u20131392. https:\/\/doi.org\/10.1093\/hmg\/ddi147 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"74042_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1471-4159.2003.01980.x","volume":"87","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. et al. Depletion of wild-type huntingtin in mouse models of neurologic diseases. J. Neurochem. 87, 101\u2013106. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01980.x (2003).","journal-title":"J. Neurochem."},{"key":"74042_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/exnr.1998.6832","volume":"152","author":"J Velier","year":"1998","unstructured":"Velier, J. et al. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol. 152, 34\u201340. https:\/\/doi.org\/10.1006\/exnr.1998.6832 (1998).","journal-title":"Exp. Neurol."},{"key":"74042_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/archneur.62.1.46","volume":"62","author":"S Gunawardena","year":"2005","unstructured":"Gunawardena, S. & Goldstein, L. S. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. Arch. Neurol. 62, 46\u201351. https:\/\/doi.org\/10.1001\/archneur.62.1.46 (2005).","journal-title":"Arch. Neurol."},{"key":"74042_CR22","doi-asserted-by":"publisher","first-page":"e0212337","DOI":"10.1371\/journal.pone.0212337","volume":"14","author":"A Tousley","year":"2019","unstructured":"Tousley, A. et al. Huntingtin associates with the actin cytoskeleton and \u03b1-actinin isoforms to influence stimulus dependent morphology changes. PLoS ONE 14, e0212337. https:\/\/doi.org\/10.1371\/journal.pone.0212337 (2019).","journal-title":"PLoS ONE"},{"key":"74042_CR23","doi-asserted-by":"publisher","first-page":"21599","DOI":"10.1074\/jbc.M112.359307","volume":"287","author":"BP Culver","year":"2012","unstructured":"Culver, B. P. et al. Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. J. Biol. Chem. 287, 21599\u201321614. https:\/\/doi.org\/10.1074\/jbc.M112.359307 (2012).","journal-title":"J. Biol. Chem."},{"key":"74042_CR24","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","volume":"19","author":"E Marcora","year":"2010","unstructured":"Marcora, E. & Kennedy, M. B. The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-\u03baB from the synapse to the nucleus. Hum. Mol. Genet. 19, 4373\u20134384. https:\/\/doi.org\/10.1093\/hmg\/ddq358 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"74042_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato, C. et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76\u201383. https:\/\/doi.org\/10.1038\/ng1219 (2003).","journal-title":"Nat. Genet."},{"key":"74042_CR26","doi-asserted-by":"publisher","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn, C. L. et al. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J. Neurosci. 28, 10720\u201310733. https:\/\/doi.org\/10.1523\/JNEUROSCI.2126-08.2008 (2008).","journal-title":"J. Neurosci."},{"key":"74042_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier, L. R. et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127\u2013138. https:\/\/doi.org\/10.1016\/j.cell.2004.06.018 (2004).","journal-title":"Cell"},{"key":"74042_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato, C. et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293, 493\u2013498 (2001).","journal-title":"Science"},{"key":"74042_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","volume":"26","author":"R Andre","year":"2016","unstructured":"Andre, R., Carty, L. & Tabrizi, S. J. Disruption of immune cell function by mutant huntingtin in Huntington\u2019s disease pathogenesis. Curr. Opin. Pharmacol. 26, 33\u201338. https:\/\/doi.org\/10.1016\/j.coph.2015.09.008 (2016).","journal-title":"Curr. Opin. Pharmacol."},{"key":"74042_CR30","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple, A. et al. Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J. Proteome Res. 6, 2833\u20132840. https:\/\/doi.org\/10.1021\/pr0700753 (2007).","journal-title":"J. Proteome Res."},{"key":"74042_CR31","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist, M. et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J. Exp. Med. 205, 1869\u20131877 (2008).","journal-title":"J. Exp. Med."},{"key":"74042_CR32","doi-asserted-by":"publisher","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","volume":"3","author":"E Wild","year":"2011","unstructured":"Wild, E. et al. Abnormal peripheral chemokine profile in Huntington\u2019s disease. PLoS Curr. 3, RRN1231. https:\/\/doi.org\/10.1371\/currents.RRN1231 (2011).","journal-title":"PLoS Curr."},{"key":"74042_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang, K. H., Wu, Y. R., Chen, Y. C. & Chen, C. M. Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav. Immun. 44, 121\u2013127. https:\/\/doi.org\/10.1016\/j.bbi.2014.09.011 (2015).","journal-title":"Brain Behav. Immun."},{"key":"74042_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp, E. et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161\u2013172 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"74042_CR35","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese, N. et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66, 1638\u20131643. https:\/\/doi.org\/10.1212\/01.wnl.0000222734.56412.17 (2006).","journal-title":"Neurology"},{"key":"74042_CR36","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai, Y. F. et al. Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130, 1759\u20131766 (2007).","journal-title":"Brain"},{"key":"74042_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hbm.21008","volume":"32","author":"M Politis","year":"2011","unstructured":"Politis, M. et al. Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: a multimodal imaging study. Hum. Brain Mapp. 32, 258\u2013270. https:\/\/doi.org\/10.1002\/hbm.21008 (2011).","journal-title":"Hum. Brain Mapp."},{"key":"74042_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling, D. et al. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145, 863\u2013874 (2011).","journal-title":"Cell"},{"key":"74042_CR39","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","volume":"32","author":"J Bouchard","year":"2012","unstructured":"Bouchard, J. et al. Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington\u2019s disease. J. Neurosci. 32, 18259\u201318268. https:\/\/doi.org\/10.1523\/JNEUROSCI.4008-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"74042_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1523\/JNEUROSCI.4846-11.2012","volume":"32","author":"W Kwan","year":"2012","unstructured":"Kwan, W. et al. Bone marrow transplantation confers modest benefits in mouse models of Huntington\u2019s disease. J. Neurosci. 32, 133\u2013142. https:\/\/doi.org\/10.1523\/JNEUROSCI.4846-11.2012 (2012).","journal-title":"J. Neurosci."},{"key":"74042_CR41","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jnc.13553","volume":"137","author":"L Dobson","year":"2016","unstructured":"Dobson, L. et al. Laquinimod dampens hyperactive cytokine production in Huntington\u2019s disease patient myeloid cells. J. Neurochem. 137, 782\u2013794. https:\/\/doi.org\/10.1111\/jnc.13553 (2016).","journal-title":"J. Neurochem."},{"key":"74042_CR42","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos, J. et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain 132, 3152\u20133164 (2009).","journal-title":"Brain"},{"key":"74042_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/glia.20838","volume":"57","author":"O Sagredo","year":"2009","unstructured":"Sagredo, O. et al. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington\u2019s disease. Glia 57, 1154\u20131167. https:\/\/doi.org\/10.1002\/glia.20838 (2009).","journal-title":"Glia"},{"key":"74042_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nbd.2014.10.012","volume":"73C","author":"U Tr\u00e4ger","year":"2014","unstructured":"Tr\u00e4ger, U. et al. Characterisation of immune cell function in fragment and full-length Huntington\u2019s disease mouse models. Neurobiol. Dis. 73C, 388\u2013398. https:\/\/doi.org\/10.1016\/j.nbd.2014.10.012 (2014).","journal-title":"Neurobiol. Dis."},{"key":"74042_CR45","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1172\/JCI64484","volume":"122","author":"W Kwan","year":"2012","unstructured":"Kwan, W. et al. Mutant huntingtin impairs immune cell migration in Huntington disease. J. Clin. Invest. 122, 4737\u20134747. https:\/\/doi.org\/10.1172\/JCI64484 (2012).","journal-title":"J. Clin. Invest."},{"key":"74042_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","volume":"137","author":"U Tr\u00e4ger","year":"2014","unstructured":"Tr\u00e4ger, U. et al. HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation. Brain 137, 819\u2013833. https:\/\/doi.org\/10.1093\/brain\/awt355 (2014).","journal-title":"Brain"},{"key":"74042_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti, A. et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat. Neurosci. 17, 513\u2013521. https:\/\/doi.org\/10.1038\/nn.3668 (2014).","journal-title":"Nat. Neurosci."},{"key":"74042_CR48","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/hmg\/ddw142","volume":"25","author":"JR Miller","year":"2016","unstructured":"Miller, J. R. et al. RNA-Seq of Huntington\u2019s disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation. Hum. Mol. Genet. 25, 2893\u20132904. https:\/\/doi.org\/10.1093\/hmg\/ddw142 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"74042_CR49","doi-asserted-by":"publisher","first-page":"46740","DOI":"10.1038\/srep46740","volume":"7","author":"JRC Miller","year":"2017","unstructured":"Miller, J. R. C. et al. Allele-selective suppression of mutant Huntingtin in primary human blood cells. Sci. Rep. 7, 46740. https:\/\/doi.org\/10.1038\/srep46740 (2017).","journal-title":"Sci. Rep."},{"key":"74042_CR50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/hmg\/ddl467","volume":"16","author":"AN Strehlow","year":"2007","unstructured":"Strehlow, A. N., Li, J. Z. & Myers, R. M. Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum. Mol Genet 16, 391\u2013409 (2007).","journal-title":"Hum. Mol Genet"},{"key":"74042_CR51","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1242\/dmm.017368","volume":"7","author":"H Brandstaetter","year":"2014","unstructured":"Brandstaetter, H., Kruppa, A. J. & Buss, F. Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane. Dis. Model. Mech. 7, 1335\u20131340. https:\/\/doi.org\/10.1242\/dmm.017368 (2014).","journal-title":"Dis. Model. Mech."},{"key":"74042_CR52","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan, J. S. et al. The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 97, 6763\u20136768. https:\/\/doi.org\/10.1073\/pnas.100110097 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74042_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1083\/jcb.200612131","volume":"178","author":"AP Manderson","year":"2007","unstructured":"Manderson, A. P., Kay, J. G., Hammond, L. A., Brown, D. L. & Stow, J. L. Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFalpha. J. Cell Biol. 178, 57\u201369. https:\/\/doi.org\/10.1083\/jcb.200612131 (2007).","journal-title":"J. Cell Biol."},{"key":"74042_CR54","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1126\/science.1120225","volume":"310","author":"RZ Murray","year":"2005","unstructured":"Murray, R. Z., Kay, J. G., Sangermani, D. G. & Stow, J. L. A role for the phagosome in cytokine secretion. Science 310, 1492\u20131495. https:\/\/doi.org\/10.1126\/science.1120225 (2005).","journal-title":"Science"},{"key":"74042_CR55","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1189\/jlb.0412191","volume":"92","author":"AC Stanley","year":"2012","unstructured":"Stanley, A. C. et al. Recycling endosome-dependent and -independent mechanisms for IL-10 secretion in LPS-activated macrophages. J. Leukoc Biol. 92, 1227\u20131239. https:\/\/doi.org\/10.1189\/jlb.0412191 (2012).","journal-title":"J. Leukoc Biol."},{"key":"74042_CR56","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1073\/pnas.0800137105","volume":"105","author":"ZZ Lieu","year":"2008","unstructured":"Lieu, Z. Z. et al. A trans-Golgi network golgin is required for the regulated secretion of TNF in activated macrophages in vivo. Proc. Natl. Acad. Sci. USA 105, 3351\u20133356. https:\/\/doi.org\/10.1073\/pnas.0800137105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74042_CR57","doi-asserted-by":"publisher","first-page":"e57034","DOI":"10.1371\/journal.pone.0057034","volume":"8","author":"M Micaroni","year":"2013","unstructured":"Micaroni, M. et al. Rab6a\/a\u2019 are important Golgi regulators of pro-inflammatory TNF secretion in macrophages. PLoS ONE 8, e57034. https:\/\/doi.org\/10.1371\/journal.pone.0057034 (2013).","journal-title":"PLoS ONE"},{"key":"74042_CR58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1083\/jcb.200706152","volume":"181","author":"Y Tian","year":"2008","unstructured":"Tian, Y. et al. Cytokine secretion requires phosphatidylcholine synthesis. J. Cell Biol. 181, 945\u2013957. https:\/\/doi.org\/10.1083\/jcb.200706152 (2008).","journal-title":"J. Cell Biol."},{"key":"74042_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1742-2094-8-50","volume":"8","author":"CL Murray","year":"2011","unstructured":"Murray, C. L., Skelly, D. T. & Cunningham, C. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1\u03b2 and IL-6. J. Neuroinflamm. 8, 50. https:\/\/doi.org\/10.1186\/1742-2094-8-50 (2011).","journal-title":"J. Neuroinflamm."},{"key":"74042_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/s0960-9822(03)00006-x","volume":"13","author":"JK Pagan","year":"2003","unstructured":"Pagan, J. K. et al. The t-SNARE syntaxin 4 is regulated during macrophage activation to function in membrane traffic and cytokine secretion. Curr. Biol. 13, 156\u2013160. https:\/\/doi.org\/10.1016\/s0960-9822(03)00006-x (2003).","journal-title":"Curr. Biol."},{"key":"74042_CR61","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.4049\/jimmunol.0802002","volume":"182","author":"C Han","year":"2009","unstructured":"Han, C. et al. Human SCAMP5, a novel secretory carrier membrane protein, facilitates calcium-triggered cytokine secretion by interaction with SNARE machinery. J. Immunol. 182, 2986\u20132996. https:\/\/doi.org\/10.4049\/jimmunol.0802002 (2009).","journal-title":"J. Immunol."},{"key":"74042_CR62","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1002\/eji.201141640","volume":"41","author":"R Mori","year":"2011","unstructured":"Mori, R. et al. Release of TNF-\u03b1 from macrophages is mediated by small GTPase Rab37. Eur. J. Immunol. 41, 3230\u20133239. https:\/\/doi.org\/10.1002\/eji.201141640 (2011).","journal-title":"Eur. J. Immunol."},{"key":"74042_CR63","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/hmg\/ddr075","volume":"20","author":"L Munsie","year":"2011","unstructured":"Munsie, L. et al. Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease. Hum. Mol. Genet. 20, 1937\u20131951. https:\/\/doi.org\/10.1093\/hmg\/ddr075 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"74042_CR64","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam, A. et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell Physiol. 233, 6425\u20136440. https:\/\/doi.org\/10.1002\/jcp.26429 (2018).","journal-title":"J. Cell Physiol."},{"key":"74042_CR65","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1165\/rcmb.2015-0012OC","volume":"53","author":"AA Tarique","year":"2015","unstructured":"Tarique, A. A. et al. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am. J. Respir. Cell Mol. Biol. 53, 676\u2013688. https:\/\/doi.org\/10.1165\/rcmb.2015-0012OC (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"74042_CR66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0006-291x(03)00764-2","volume":"305","author":"CM Cheng","year":"2003","unstructured":"Cheng, C. M., Huang, S. P., Chang, Y. F., Chung, W. Y. & Yuo, C. Y. The viral death protein Apoptin interacts with Hippi, the protein interactor of Huntingtin-interacting protein 1. Biochem. Biophys. Res. Commun. 305, 359\u2013364. https:\/\/doi.org\/10.1016\/s0006-291x(03)00764-2 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"74042_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncb735","volume":"4","author":"FG Gervais","year":"2002","unstructured":"Gervais, F. G. et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol. 4, 95\u2013105. https:\/\/doi.org\/10.1038\/ncb735 (2002).","journal-title":"Nat. Cell Biol."},{"key":"74042_CR68","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting Huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316. https:\/\/doi.org\/10.1056\/NEJMoa1900907 (2019).","journal-title":"N. Engl. J. Med."},{"key":"74042_CR69","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.neuron.2019.05.001","volume":"102","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J., Ghosh, R. & Leavitt, B. R. Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron 102, 899. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.001 (2019).","journal-title":"Neuron"},{"key":"74042_CR70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/awz363","volume":"143","author":"JD Crapser","year":"2020","unstructured":"Crapser, J. D. et al. Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington\u2019s disease. Brain 143, 266\u2013288. https:\/\/doi.org\/10.1093\/brain\/awz363 (2020).","journal-title":"Brain"},{"key":"74042_CR71","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/BJ20110352","volume":"436","author":"GJ Tesz","year":"2011","unstructured":"Tesz, G. J. et al. Glucan particles for selective delivery of siRNA to phagocytic cells in mice. Biochem. J. 436, 351\u2013362. https:\/\/doi.org\/10.1042\/BJ20110352 (2011).","journal-title":"Biochem. J."},{"key":"74042_CR72","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M. et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 104, 17204\u201317209. https:\/\/doi.org\/10.1073\/pnas.0708285104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74042-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:05:39Z","timestamp":1670360739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74042-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74042"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74042-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Through the offices of UCL Consultants Ltd, a wholly owned subsidiary of University College London, S.J.T. has undertaken consultancy services for Alnylam Pharmaceuticals Inc, Annexon Inc, DDF Discovery Ltd, F. Hoffmann-La Roche AG, Genentech Inc, GlaxoSmithKline plc, Novartis AG, Takeda Pharmaceuticals Ltd, Teva Pharmaceuticals Ltd, Triplet Theraputics Inc, UCB S.A., University College Irvine and Vertex Pharmaceuticals Inc. The other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17269"}}